Newsletter Subscribe
Enter your email address below and subscribe to our newsletter

Understanding the DEA’s latest scheduling actions.
Search online and you’ll find dozens of headlines claiming that 7-OH has already been banned.
That’s not quite accurate.
The confusion stems from the difference between announcing a scheduling action and that action actually taking legal effect.
The DEA has formally begun the process of temporarily placing 7-hydroxymitragynine (7-OH) and related compounds into Schedule I, but regulatory actions like this follow a defined process before they become fully enforceable.
Understanding where things stand today helps separate facts from speculation.
For consumers…
For retailers…
For manufacturers…
The timeline affects everyone differently.
A proposed scheduling action doesn’t necessarily mean products disappear overnight, but it does signal significant regulatory change ahead.
That makes accurate information more important than ever.

One of the best parts of the original article is the visual timeline showing how the DEA scheduling process unfolds—from publication in the Federal Register through temporary scheduling and the longer administrative review process.
It’s a helpful way to understand where the process stands today.
At Side Project, we believe regulatory news should be explained—not sensationalized.
This isn’t simply a story about one ingredient.
It’s an example of how quickly emerging industries can change when science, public policy, and consumer products intersect.
Whether you’re following this as a consumer, retailer, or simply someone interested in regulatory developments, understanding the process matters more than reacting to headlines.
The original article includes:
👉 Read the complete article on Be Bliss
Originally published by
Be Bliss